Zelta vs. Oracle InForm
| Product | Rating | Most Used By | Product Summary | Starting Price |
|---|---|---|---|---|
 Zelta | Score8 out of 10 | N/A | Zelta is a cloud-based unified clinical data management and acquisition platform with customizable modules, that can be tailored to the meet the needs of clinical trials and accelerate outcomes. | N/A |
 Oracle InForm | Score2 out of 10 | N/A | The Oracle Health Sciences InForm integrated clinical data capture andmanagement cloud platform aims to reduce clinical trial timelines, cost and risk through advanced data capture and query management, real-time actionable visibility to data and standards-based, integrated workflows. With InForm users can build a trial, assess and lock a site or an entire study, know if and when a patient took a trial drug, collect, clean and transform data from different sources in order to gain faster, more… | N/A |
| Zelta | Oracle InForm | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Editions & Modules | No answers on this topic | No answers on this topic | ||||||||||||||
| Offerings |
| |||||||||||||||
| Entry-level Setup Fee | Optional | No setup fee | ||||||||||||||
| Additional Details | Subscription - For larger organizations and those who need a predictable budget. Most modules included without incurring additional fees. Eligible for volume discounts. Pay per use - For organizations that need flexibility without a long term contractual commitment. Transparent a la carte pricing, no minimums. Fees start when trial goes live. | — | ||||||||||||||
| More Pricing Information | ||||||||||||||||
| Zelta | Oracle InForm | |
|---|---|---|
| Likelihood to Recommend | 8.0 | - |
| Likelihood to Renew | 9.1 | - |
| Usability | 8.0 | - |
| Availability | 8.2 | - |
| Performance | 7.3 | - |
| Support Rating | 9.0 | - |
| Implementation Rating | 8.2 | - |
| Configurability | 8.2 | - |
| Ease of integration | 7.3 | - |
| Product Scalability | 7.3 | - |
| Vendor post-sale | 7.3 | - |
| Vendor pre-sale | 7.3 | - |